Ruth A. Keri

机构：Cleveland Clinic, University Hospitals Seidman Cancer Center, Case Western Reserve University · ORCID：0000-0002-1640-3088

发表论文 446 篇 · 总被引 6819 次 · h-index 43

代表论文

• Integrated collagen architecture and composition improve risk stratification in triple-negative breast cancer (2026 · Neoplasia)
• The small molecule inhibitor SU056-mediated targeting of YB1 inhibits the Rb pathway in triple negative breast cancer tumors (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• Novel transplantable mouse cell line model recapitulates invasive lobular breast carcinoma (ILC) phenotype and immune microenvironment. (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• Supplemental Table 3 from Targeting YES1 Disrupts Mitotic Fidelity and Potentiates the Response to Taxanes in Triple-Negative Breast Cancer (2026)
• Figure S3 from Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors (2026)
• Figure S8 from Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors (2026)